SCIENTIFIC VALIDATION OF ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF TECOMA STANS (L) JUSS. LEAF

Fuente: Zenodo
Saved in:
Bibliographic Details
Main Authors: Bhupendra Rodle*, Dr. Sachin K. Jain
Format: Recurso digital
Language:English
Published: Zenodo 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866901369806389248
author Bhupendra Rodle*
Dr. Sachin K. Jain
author_facet Bhupendra Rodle*
Dr. Sachin K. Jain
contents <p><span>The objective of this study was To Scientific Validation of Antidiabetic Activity of Ethanolic Extract of Tecoma Stans (L) Juss. Leaf. The plant leaves were collected locally from the herbal store and botanical garden of the garden of the botany central council for Research Ayurveda and Siddha Govt. of India .The plant was identified and authenticated by comparison with herbarium specimens. The leaves of Tecoma Stans (L.) juss ex kunth were authenticated by comparison with herbarium specimens and authentication No. BSI/SRC5/23/2016/Tec/1993. The different extracts (alcoholic and aqueous) of Tecoma Stans were subjected to physicochemical analysis. Tests for carbohydrates, phenols, tannins, alkaloids, flavonoids, fats, glycosides, steroids, amino acids, proteins carbohydrates, proteins, amino acids, flavonoids, saponins, phenol and tannins which may probably responsible for their expected pharmacological action. In the toxicity studies ethanolic extract did not show any signs or symptoms of toxicity in ratsat doses up to 2000 mg/kg p.o., indicating that it has no toxicity at the maximal doses tested in this work. The extract with maximum number of phytoconstituents and extractive value identified (ethanolic) is used in the further evaluations. Toxicity study shows the safety nature of the extract and also acute and sub-acute toxicity studies do not produce any toxic symptoms upto 500 mg/kg. The extract was pre-clinically evaluated against STZ induced diabetic rats models for its antidiabetic activity. The extract showed insulin mimetic activity and control of blood sugar level which are comparable to the reference drug glibenclamide at a dose of 10mg/kg. as the invivoresults indication has been concluded 50% ethanolic extract of Tecoma Stans (L), which may be containing structurally insulin resembled compounds. In conclusion the extract is safe and can be used to treat diabetic conditions without any harmful effects. </span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_14966505
institution Zenodo
language eng
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle SCIENTIFIC VALIDATION OF ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF TECOMA STANS (L) JUSS. LEAF
Bhupendra Rodle*
Dr. Sachin K. Jain
Herbarium specimens
Tecoma Stans (L) Juss. Leaf
Zeta potential
antidiabetic
Validation
<p><span>The objective of this study was To Scientific Validation of Antidiabetic Activity of Ethanolic Extract of Tecoma Stans (L) Juss. Leaf. The plant leaves were collected locally from the herbal store and botanical garden of the garden of the botany central council for Research Ayurveda and Siddha Govt. of India .The plant was identified and authenticated by comparison with herbarium specimens. The leaves of Tecoma Stans (L.) juss ex kunth were authenticated by comparison with herbarium specimens and authentication No. BSI/SRC5/23/2016/Tec/1993. The different extracts (alcoholic and aqueous) of Tecoma Stans were subjected to physicochemical analysis. Tests for carbohydrates, phenols, tannins, alkaloids, flavonoids, fats, glycosides, steroids, amino acids, proteins carbohydrates, proteins, amino acids, flavonoids, saponins, phenol and tannins which may probably responsible for their expected pharmacological action. In the toxicity studies ethanolic extract did not show any signs or symptoms of toxicity in ratsat doses up to 2000 mg/kg p.o., indicating that it has no toxicity at the maximal doses tested in this work. The extract with maximum number of phytoconstituents and extractive value identified (ethanolic) is used in the further evaluations. Toxicity study shows the safety nature of the extract and also acute and sub-acute toxicity studies do not produce any toxic symptoms upto 500 mg/kg. The extract was pre-clinically evaluated against STZ induced diabetic rats models for its antidiabetic activity. The extract showed insulin mimetic activity and control of blood sugar level which are comparable to the reference drug glibenclamide at a dose of 10mg/kg. as the invivoresults indication has been concluded 50% ethanolic extract of Tecoma Stans (L), which may be containing structurally insulin resembled compounds. In conclusion the extract is safe and can be used to treat diabetic conditions without any harmful effects. </span></p>
title SCIENTIFIC VALIDATION OF ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF TECOMA STANS (L) JUSS. LEAF
topic Herbarium specimens
Tecoma Stans (L) Juss. Leaf
Zeta potential
antidiabetic
Validation
url https://doi.org/10.5281/zenodo.14966505